Lifeboat Foundation

VetiGel: A way to instantly stop bleeding.

A 17-year-old invented an ingenious way to instantly stop bleeding.

Read more

Samsung’s already wide product family is getting even bigger thanks to its new chip dubbed the “Samsung Bio-Processor.” As the company tells it, it’s already in mass production and is “specifically designed to allow accelerated development of innovative wearable products for consumers who are increasingly monitoring their health and fitness on a daily basis.” Phew. The announcement post goes on to say that the processor is the first all-in-one health solution chip and that since it’s packing a number of different control and sensor units (like a quintet of Analog Front Ends, a microcontroller unit, digital signal processor and eFlash memory) it can do all these tricks without the need for external processing.

The idea behind the silicon is to be the one-stop wearable fitness resource. Those five AFEs? One keeps track of bioelectrical impedance analysis, while the others focus on volumetric measurements of organs, an electrocardiogram and skin temperature, among other things. Bear in mind that Samsung’s latest smartwatch, the Gear S2, only tracks your heart rate. Same goes for the Apple Watch. Considering how err… interesting Samsung wearables tend to be, a possible scenario here is that the tech giant won’t keep the Bio-Processor all to itself. Nope, the real money here lies in potentially licensing it out to other folks, as it’s wont to do with its other self-made parts.

We won’t have to wait too long to see these in the wild, either: Samsung promises it’ll be packed into devices available early next year. If you’re wondering where, the inevitable follow-up to the aforementioned Gear S2 successor is a pretty likely bet. Whether that shows its face at CES or Mobile World Congress is the real question, though.

Read more

Small Form Factor Technology Solves Complexities of Thought-Controlled Leg Prosthetics

Rehabilitation Institute of Chicago has developed the first neural-controlled bionic leg, using no nerve redirection surgery or implanted sensors. It’s a powerful advancement in prosthetics, including motorized knee and ankle, and control enabled by the patient’s own neural signals. Powered by a tiny but powerful Computer-on-Module platform, this thought-controlled prosthetic represents a significant breakthrough in medical embedded design, improving patients’ lives and mobility with a prosthetic that more closely than ever acts like a fully-functioning natural limb.

The technology of prosthetic limbs has come a long way over time, yet options are still limited for leg amputees. While simple peg legs have evolved to more sophisticated and realistic artificial limbs, the patient was forced to undergo nerve surgery or endure invasive implants. And even though the technology to produce through-controlled mechanized arms has existed for some time, the complexities of leg motion have kept it from being successfully applied in leg prosthetics. Without the ability to move and control the knee and ankle, the prosthetic leg remained a passive solution for patients struggling to replicate natural leg motion.

Read more

My new article for Vice Motherboard. It’s about one of the biggest ideas I believe in–the necessity to spend more money directly on science goals instead of bomb making and defense:

It just so happens that there is another way—a method that would satisfy liberals and conservatives alike. Instead of always spending more on our military, we could transition our nation and its economy into a scientific-industrial complex.

There’s compelling reason to do this beyond what meets the eye. Transhumanist technology is starting to radically change human life. Many experts expect to be able to stop aging and conquer death for human beings in the next 25 years. Others, like myself, see humans merging with machines and replacing our every organ with bionic ones.

Continue reading “We Must Cut the Military and Transition to a Science-Industrial Complex” »

Speculations around whether biotech stocks are in a bubble remain undecided for the second year in a row. But one thing stands as indisputable—the field made massive progress during 2015, and faster than anticipated.

For those following the industry in recent years, this shouldn’t come as a surprise.

In fact, according to Adam Feuerstei at The Street, some twenty-eight biotech and drugs stocks grew their market caps to $1 billion or more in 2014, and major headlines like, “Human Genome Sequencing Now Under $1,000 Per Person,” were strewn across the web last year.

Read more

Futurism presents its annual This Year in Science immersive experience! This year’s themes include robot intelligence, space exploration, drones, CRISPR (a breakthrough gene editing tool), plus a special ‘Futurist of the Year’ award.

Read more

https://lifeboat.com/blog.images/dna-nanobots-will-target-ca...tient.jpg">

BY: DANIEL KORN

The very mention of “nanobots” can bring up a certain future paranoia in people—undetectable robots under my skin? Thanks, but no thanks. Professor Ido Bachelet of Israel’s Bar-Ilan University confirms that while tiny robots being injected into a human body to fight disease might sound like science fiction, it is in fact very real.

Cancer treatment as we know it is problematic because it targets a large area. Chemo and radiation therapies are like setting off a bomb—they destroy cancerous cells, but in the process also damage the healthy ones surrounding it. This is why these therapies are sometimes as harmful as the cancer itself. Thus, the dilemma with curing cancer is not in finding treatments that can wipe out the cancerous cells, but ones that can do so without creating a bevy of additional medical issues. As Bachelet himself notes in a TEDMED talk: “searching for a safer cancer drug is basically like searching for a gun that kills only bad people.”

Read more

At one time or another, we’ve all been encouraged to “maximize our potential.” In a recent interview, Academic and Entrepreneur Juan Enriquez said that mankind is making progress toward expanding beyond its potential. And the changes, he believes, could be profound.

To illustrate the process, Enriquez theorized what might happen if we were to bring Charles Darwin back to life and drop him in the middle of Trafalgar Square. As Darwin takes out his notebook and starts observing, Enriquez suggested he would likely see what might appear to be a different species. Since Darwin’s time, humans have grown taller, and with 1.5 billion obese people, larger. Darwin might also notice some other features too that many of us take for granted — there are more senior citizens, more people with all their teeth, a lot fewer wrinkles, and even some 70-year-olds running in marathons.

“There’s a whole series of morphologies that are just different about our bodies, but we don’t notice it. We don’t notice we’ve doubled the lifespan of humans in the last century,” Enriquez said. “We don’t notice how many more informations (sic) come into a brain in a single day versus what used to come in in a lifetime. So, across almost every part of humanity, there have been huge changes.”

Part of the difference that Darwin would see, Enriquez noted, is that natural selection no longer applies as strongly to life and death as it once did. Further, random gene mutations that led to some advantages kept getting passed down to generations and became part of the species. The largest difference, however, is our ongoing move toward intelligent design, he said.

Continue reading “Can We Evolve Ourselves To Expand Beyond Human Potential?” »

A Chinese company building a massive animal cloning facility doesn’t want to limit itself to just replicating cattle and pets but hopes to move into the human cloning business in the future. The company, Boyalife Group, possesses the technology to do so, its CEO, Xiaochun Xo, told AFP, but to date has been “self-restrained” because it fears public backlash.

A Chinese company is claiming it has the technology to clone humans but is holding off because it says the public isn’t ready. That’s likely true, experts say, and it’s not likely to change because there isn’t a powerful enough medical reason that could swing public opinion.

Read more